AIDS Treatment News - 1999

• AIDS Treatment News - 1999
• Issue #310
• 1999: Treatments, Issues to Watch
• Ziagen(tm) (Abacavir) Approved: Caution Essential
• Improving Drug Development: Exploratory Clinical Studies
• Robert Gallo Calls for New Treatment Approach
• Altered Body Shape: Teleconference January 20, Recording, Transcript Available
• West Indies Conference: Report on Web
• Writer Needs Help: Legal Defense Fund
• San Francisco: HMO Coverage of Acupuncture
• AIDS Treatment News Financial Disclosure Update


• Issue #311
• New Healthcare Economics Threaten HIV Specialization, Patient Choice, & Quality Care
• Retroviruses Conference Coverage on the Web
• AIDS Treatment News Next Issue Delayed One Week
• HIV Therapy: Retroviruses Meeting Report by Telephone Conference, February 4
• Help Wanted, San Francisco: Recruitment Coordinator and Health Educator, Resume Due Jan. 29
• Global PWA Conference in Warsaw, August 13-19
• A Visit to India: Drug Prices, Research, & Global Access


• Issue #312
• Retroviruses Conference, Chicago 1999
• Restoring HIV-Specific Immunity
• HIV-Specific Immunity: Major Conference Sessions
• Houston, April 30: Eleventh Annual Houston Conference on AIDS in America
• 3rd International Conference on Nutrition and HIV Infection (Focusing on Metabolic Complications), Cannes, France, April
• International Health: Preparing for the 21st Century, San Francisco, February 27


• Issue #313
• Kaposi's Sarcoma: New Topical Treatment Approved
• Retroviruses Conference: Finding Information on the Web
• Strategy Trials: The Answer?
• San Francisco: New HMO Problems Threaten Access to Care
• Tuberculosis Control: Many Cases Found Transmitted Despite Negative Result on Standard Test
• Keep Your Medicare In Force As You Go Back to Work (What To Do And When To Do It)
• Medical Marijuana: Major AIDS Organizations Seek Legal Access
• Washington D.C.: Retroviruses Conference Update, February 25
• 11th National HIV/AIDS Update Conference, San Francisco, March 23-26


• Issue #314
• Compulsory Licensing for Bridging the Gap--Treatment Access in Developing Countries: Interview with James Love, Consumer
• Viral Load 50-Copy Test Approved
• Neuropathy: Nutritional Prevention/Treatment Suggested
• National AIDS Update, San Francisco, March 23-26: Treatment, Science Coverage
• Los Angeles: Activist Training, March 27


• Issue #315
• Lipodystrophy: Glaxo Researchers Suggest Mechanisms, Publish Data
• New Antiviral Substances Found with HCG
• Health GAP Coalition - New Group for International Treatment Access
• African-American AIDS Conference Full, Available on Web
• Medical Marijuana: Major Report Released March 17
• California: 9th Annual AIDS Lobby Day, April 19
• San Francisco Area: Important Cyclosporin Study Recruiting


• Issue #316
• Viral Resistance Testing: Practical Issues and Future Opportunities - Interview with Thomas Merigan, M.D.
• Medicare Recipients - New Income Limits Can Increase Cash, Medical Benefits
• Federal Employees - New Life Insurance Option April 1 - May 31 Only
• Vaccine and Microbicide Tax Credit Legislation Introduced in Congress
• AIDSWatch Federal Lobby Days, May 2-4 in D.C.
• Washington: Demonstration on Africa Trade Bills and AIDS Drug Access, April 21


• Issue #317
• New Frontier of AIDS Activism: International Trade Rules and Global Access to Medicines - Interview with Eric Sawyer, HIV
• Poppers: Large Cancer Increase and Immune Suppression in Animal Tests
• Federal Guidelines for Treatment of HIV: Free Telephone Conference May 10
• Online Chat with Expert Physician, April 28
• T-Cell Activation Predictive of Poor Survival in Advanced Disease
• Fish Oil Reduced Heart Disease in Controlled Trial
• San Francisco General Outpatient Pharmacy Problems
• Clinton/Gore Top Staffs: Pharmaceutical Background


• Issue #318
• Amprenavir, New Protease Inhibitor, Approved
• VIAGRA: New Warning with Protease Inhibitors
• Interrupting HAART; Hydroxyurea; Five+ Drug Therapy--Report from the RIGHT Conference
• Gates Foundation Donates $25 Million for AIDS Vaccine
• Lipodystrophy Conference, June 26-28 in San Diego
• Managed Care Problems: San Francisco Hearing Set for May 13
• Model AIDS Program Housed in African-American Church
• Africa and HIV/AIDS:Email Communication List
• African American Treatment Advocacy Funding Available, May 14 Deadline
• U.S. Vaccine Trial: New Email List
• Corrections, Issue #317
• International AIDS Candlelight Memorial and Mobilization, May 16
• California Alert: Oppose HIV Names Reporting


• Issue #319
• REMUNE Trial Will Stop; New Trials Planned
• Telephone Conference Call June 7 on HIV Treatment
• Updated HIV Treatment Guidelines Available
• Hundred Million Dollar Program for Public-Private AIDS Research and Outreach in Africa
• Medicaid Early Treatment Bill Now in Congress
• Medical Marijuana: AIDS-Related Information in the New Federal Report


• Issue #320
• Eradication or Immune Control: New Research, Issue of Focus
• Treatment Interruption Research: The Trial Most Needed Now
• HE2000 Begins Clinical Trials: Interview with James Frincke, Ph.D.
• Salvage Therapy Workshop in Toronto: Reports on Web
• Threat to Compounding of Topical Testosterone, Other Pharmaceuticals: FDA Proposes Limit on Interstate Shipment
• Panama: Modern Antiretroviral Treatment Will Be Available
• AEGIS Nominated to UNESCO "Memory of the World"


• Issue #321
• Neuropathy: Call for Information on Voltaren Emulgel (Topical Diclofenac Sodium)
• India Research Opportunities, Price and Patent Problems: Interview with David Scondras
• Salvage Therapy Workshop: More Web Reports
• FDA Public Meeting on Dietary Supplement Regulation, Oakland, CA, July 20, Register by July 14; Written Comment Deadline
• Action Alert: Drug-Patent Bill Could Cost Patients $3 Billion+; Hearing July 1


• Issue #322
• Ritonavir (Norvir (R) ) Capsules Back: Refrigeration Optional
• Organ Transplants: One Million Dollars for Research
• Immune Reconstitution: New Review on Web
• Ribavirin for Hepatitis C: 80% Price Reduction Available July 9?
• Medical Marijuana: California Task Force Proposes Registration System; Hearing Set for July 13
• Africa, Access, and Patents: Moving Fast


• Issue #323
• Major Advance in Protecting Newborns: One Nevirapine Dose Cuts Infection in Half
• T-20: 5-Drug Combination Trial for Heavily Treated NNRTI- Naive Patients Now Recruiting
• ICAAC Conference in San Francisco, September 26-29
• Resistance Conference Reports
• Current HIV Treatment Review on Web
• Web-Based Survey: Symptom Management for Persons Living with HIV
• African American: Conference Dates Set
• New York Area and Worldwide: Call-In Radio Program on HIV
• Help Wanted: National Treatment Educator and Medical Advocate, Los Angeles
• Charges Dropped in Sex Sting; Protecting Yourself Online


• Issue #324
• Diarrhea: New Treatment Option from Shaman
• International AIDS Treatment Momentum: Interview with Paul Boneberg, Global AIDS Action Network
• FDA Hearing Highlights Opposition to Dietary Supplement Practices; Written Comments Due
• AIDS Treatment News Statement for Africa Hearing
• Statement on Needle Exchange


• Issue #325
• Upcoming Research and Treatment Conferences, Meetings
• Retroviruses Conference Dates and Deadlines
• United States Conference on AIDS, Nov. 5-8 in Denver
• 1999 National Conference on Women and HIV/AIDS, Los Angeles, October 9-12, Scholarship Deadline Sept. 1
• Growth Hormone Symposium, October 7-10, 1999
• Lymphoma Patient Educational Forum, October 16-17, Manhattan Beach
• AIDS Jobs Available
• San Francisco General Hospital: Studies for Patients Beginning Antiretroviral Treatment
• Poppers: More Evidence of Suppressed Immunity


• Issue #326
• Lipodystrophy: Free Teleconference Sept. 15, Tape and Transcript Available Later
• Opportunistic Infections: New Treatment Guidelines Published August 20
• HIV & AIDS Treatment Registry Database: Public Registry Now Online
• Treatment Advocacy Program Trains 200: Interview with Matt Sharp
• Activists Block Gore's Office to Protest Terms of Africa Deal
• Brazil May Stop HIV Drug Access; Problems Also Reported from Argentina
• Seattle Demonstration Preparations for Global Trade Meeting


• Issue #327
• Biological Treatment Approaches, Including Tat Toxoid Vaccine: Interview with Robert Gallo, M.D.
• Vaporizers for Medical Marijuana
• Teleconference September 29: Treatment News from ICAAC Conference
• Teleconference October 12: National Conference on Women and HIV/AIDS
• Washington Physicians' Panel on AIDS: Video Available


• Issue #328
• ABT-378 Early Access Program Begins
• ICAAC Conference Reports on the Web
• ICAAC: New Drugs in Late Breaker Session
• New AmFAR Treatment Directory Now Available
• Medicaid: You Don't Always Have to Be "Disabled"


• Issue #329
• IL-2 Low Dose and Treatment Interruption: Interview with Kendall A. Smith, M.D.
• Retroviruses Conference: Community Press Registration Deadline November 12
• Women and HIV/AIDS Conference: Tape, Web Reports Available
• FDA Advisory Meetings: Adefovir, Nov. 1; Resistance Testing Nov. 2-3


• Issue #330
• Tenofovir (PMPA) Compassionate Access Study Opens
• ddI: FDA Approves Once-Daily Dosing
• Adefovir: FDA Committee Votes Against Approval
• Activism Today: The Coalition for Salvage Therapy. Interview with Linda Grinberg
• Durban Conference: February Deadlines, New Track, and Community Program
• Simultaneous Conferences Last Week: Lisbon, Paris, and Kuala Lumpur
• Flyer for Progressives
• Pharmaceutical Patents and Developing Countries


• Issue #331
• ddI, d4T, Hydroxyurea: New Pancreatitis Warning
• Restoring HIV-Specific Immunity: Telephone Conference December 8
• Update on Tenofovir (PMPA) Compassionate Access Study
• National AIDS Treatment Advocates Forum (NATAF), Dec. 11-14, Miami Beach
• FDA Clarifies Rules, Allows Combining Antiretrovirals in Clinical Trials
• Seattle Trade Meeting: What Can Be Done for Treatment Access? Interview with James Love
• Internet Fundraising: Online Auctions Now for AIDS Project Los Angeles, San Francisco AIDS Foundation; Online Donation Av


• Issue #332
• Treatment and Related AIDS Email Lists
• Copyright Restrictions Block Non-English AIDS Information
• Hydroxychloroquine+ddI+Hydroxyurea Antiretroviral Trial, AIDS Research Alliance, Los Angeles


• Issue #333
• AIDS Treatment News Millennium Plans
• San Francisco General Hospital Funding Crisis: Call for Information
• Northern California: One-Day Advocacy Conference, January 29
• Medical Donations for Cuba
• Help Wanted, News Producer, UCSF Web Site
• Buyers' Club List, December 1999
• AIDS Treatment News Index, 1999

All information on AIDS.ORG is designed to support, but not replace your relationship with your doctor, and is intended soley for educational or research purposes. Any and all personal information you may provide us with is never released to anyone at any time. Your privacy and trust is extremely important to us.

• News
• Topics
• Experience
• Donate
• About Us

• Headlines
• AIDS Treatment News